- Home
- CYH vs CBLL Comparison
CYH vs CBLL Comparison
Compare CYH & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- CBLL
- Stock Information
- Founded
- CYH 1985
- CBLL 2014
- Country
- CYH United States
- CBLL United States
- Employees
- CYH N/A
- CBLL N/A
- Industry
- CYH Hospital/Nursing Management
- CBLL
- Sector
- CYH Health Care
- CBLL
- Exchange
- CYH Nasdaq
- CBLL Nasdaq
- Market Cap
- CYH 410.5M
- CBLL 428.8M
- IPO Year
- CYH 1991
- CBLL 2024
- Fundamental
- Price
- CYH $3.15
- CBLL $14.78
- Analyst Decision
- CYH Hold
- CBLL Strong Buy
- Analyst Count
- CYH 8
- CBLL 5
- Target Price
- CYH $3.73
- CBLL $24.20
- AVG Volume (30 Days)
- CYH 2.1M
- CBLL 360.6K
- Earning Date
- CYH 10-23-2025
- CBLL 11-04-2025
- Dividend Yield
- CYH N/A
- CBLL N/A
- EPS Growth
- CYH N/A
- CBLL N/A
- EPS
- CYH 2.47
- CBLL N/A
- Revenue
- CYH $12,644,000,000.00
- CBLL $82,813,000.00
- Revenue This Year
- CYH $0.06
- CBLL $35.50
- Revenue Next Year
- CYH $2.13
- CBLL $28.24
- P/E Ratio
- CYH $1.27
- CBLL N/A
- Revenue Growth
- CYH 0.74
- CBLL 37.93
- 52 Week Low
- CYH $2.24
- CBLL $10.01
- 52 Week High
- CYH $4.47
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- CYH 43.07
- CBLL 72.64
- Support Level
- CYH $2.90
- CBLL $12.36
- Resistance Level
- CYH $3.93
- CBLL $13.15
- Average True Range (ATR)
- CYH 0.18
- CBLL 0.68
- MACD
- CYH -0.10
- CBLL 0.28
- Stochastic Oscillator
- CYH 22.93
- CBLL 99.30
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.